Covaxin was developed by Bharat Biotech in partnership with the Indian Council of Medical Research, the government's apex research body. The vaccine ...
News
- WHO authorizes Indian-made COVID vaccine, months into use | WOAI
- WHO approval will expedite Covaxin regulatory approval in other countries: Bharat Biotech
The approval of the World Health Organisation WHO for emergency use listing of Covid-19 vaccine COVAXIN will lead to the expedition of regulatory ...
- Cerus: Q3 Earnings Snapshot - San Antonio Express-News
The biomedical products company posted revenue of $36.1 million in the period. Cerus expects full-year revenue in the range of $127 million to ...
- Regenxbio: Q3 Earnings Snapshot - mySA
'Trump lost' billboards are turning heads in San Antonio ... The biotechnology company posted revenue of $30.8 million in the period.
- We can break the cycle of poverty through bold vision for our children - San Antonio Report
... like aerospace, bioscience, cybersecurity, financial services, manufacturing, and technology. San Antonio will be known as a solutions-driven ...
